Lenzilumab (KB 003) is a humanized granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibody that directly binds to GM-CSF and prevents signaling through its receptor, and can be used to study COVID-19.
Purity:
95.00%
CAS Number:
[1229575-09-0]
Target:
c-Fms|||SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted